Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science
- Discovery Boost Grants (DBG)
- Arizona (AZ) Discovery Boost Grants (DBG)
- Mission Boost Grants (MBG)
- Research Scholar Grants
- Postdoctoral Fellowships
- Clinician Scientist Development Grant (CSDG)
- ASTRO-ACS Clinician Scientist Development Grant (CSDG)
- Institutional Research Grants
- RFA: Leukemia Exploration and Prevention Grant Program (LEAP)
- RFA: ACS IMPACT - Expanding Prostate Cancer Clinical Trials in the Community
- RFA: Extramural Discovery Science Accelerator Award
- RFA: Cancer Health Equity Research Centers
- IMPACT RFA to Support Research to Reduce Prostate Cancer Mortality
- RFA: Real-World Data Impact Award (RWIA)
- TheoryLab Collaborative (TLC) Grant
- RFA: The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
- ACS Professor Award
- Extramural Grants Department Staff Contacts
- Definition of Research Areas
- FAQs: ACS Extramural Discovery Science and Grant Application Submissions
- Extramural Priority Research Areas
- Our Grant Process
- American Cancer Society Research Events
- Peer Review Committee for DNA Mechanisms in Cancer (DMC)
- Peer Review Committee for Immunology and Blood Cell Development (IBCD)
- Peer Review Committee for RNA Mechanisms in Cancer (RMC)
- Peer Review Committee for Tumor Biochemistry and Endocrinology (TBE)
- Peer Review Committee for Cancer Cell Biology (CCB)
- Peer Review Committee for Cancer Detection and Progression (CDP)
- Peer Review Committee for Experimental Therapeutics (ET)
- Peer Review Committee for Metastasis and Microenvironment (MM)
- Peer Review Committee for Cancer Prevention and Health Promotion (CPHP)
- Peer Review Committee for Treatment, Palliative Care, and Survivorship Research
- Peer Review Committee for Etiology, Screening, and Early Detection (ESED)
- Peer Review Committee for Healthcare Outcomes, Policy, and Systems Research (HOPS)
- ACS Professor Peer Review Committee
- Peer Review Committee for Institutional Research Grants (IRG)
- Molecular Biology and Biochemistry (PF-MBB)
- Cell Biology and Immunology (PF-CBI)
- Cancer Detection and Experimental Therapeutics (PF-CDET)
- Clinical and Population Sciences (PF-CPS)
- Peer Review Committee for Mission Boost Grants
- Discovery Scientific Council
- Community Research Partner Participation on Grant Peer Review Committees
- American Cancer Society Professors
- Nobel Laureates and the American Cancer Society
IMPACT RFA to Support Research to Reduce Prostate Cancer Mortality
Application Deadline: October 15, 2024
Purpose
Prostate cancer is the second leading cause of cancer mortality among men in the United States. After decades of decline, the incidence of de novo metastatic prostate cancer diagnoses is increasing and alarmingly, Black men have more than twice as high a likelihood of death from prostate cancer than White men. The American Cancer Society (ACS) is committed to reducing the burden of prostate cancer and improving prostate cancer outcomes for all men by addressing its root causes.
To address the public health burden of prostate cancer, ACS has launched the IMPACT Initiative – Improving Mortality from Prostate CAncer Together. To bolster our strategic research efforts, ACS will fund research projects focused on reducing prostate cancer mortality and improving outcomes for all. Priority will be given to applications with direct relevance to reducing health disparities in prostate cancer mortality.
As part of our ongoing efforts, a consortium of IMPACT Investigators will meet annually to share research findings and facilitate collaborations.
Scientific Scope
Successful applications will propose studies with direct application to reducing prostate cancer mortality. Studies may span a variety of study designs and approach addressing mortality from any aspect. Possible research topics could include, but are not limited to:
- Increasing uptake of screening
- Healthy behaviors that reduce mortality in prostate cancer survivors
- Improving treatment outcomes in prostate cancer patients
- Developing novel targets for treatment
- Addressing risk factors for aggressive prostate cancers
- Increasing participation in clinical trials